Success Story: NIW Approval for Research Improving Heart Failure Self-Management and Care
Client’s Testimonial:
"An exceptional team from start to finish. Their communication, attention to detail, and genuine care gave me complete confidence throughout the process. I am incredibly grateful to them for securing my EB-2 NIW approval and helping make this life-changing milestone possible.”
On August 12th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Expert in the Field of Cardiovascular Outcomes Research (Approval Notice).
General Field: Cardiovascular Outcomes Research
Position at the Time of Case Filing: No
Country of Origin: The Philippines
State of Residence at the Time of Filing: Maryland
Approval Notice Date: August 12th, 2026
Processing Time: 2 months, 15 days (Premium Processing Requested)
Case Summary:
For patients with heart failure, outcomes depend not only on clinical treatment but also on everyday decisions such as taking medications consistently, recognizing changes in symptoms, and knowing when to seek additional care. This practical challenge formed the basis of the client’s proposed endeavor to develop and evaluate behavioral economics-informed interventions that strengthen medication adherence, symptom monitoring, patient decision-making, and timely care escalation. North America Immigration Law Group (Chen Immigration Law Associates) demonstrated how these strategies could support nurse-led heart failure self-management, enable earlier clinical intervention, reduce avoidable hospitalizations, and strengthen chronic disease care delivery. The case also connected these goals to the substantial health and economic burden of heart failure in the United States.
The client brought a combination of healthcare experience and a substantial scholarly record to this endeavor. The evidence included:
- A master's degree in health economics, outcomes research, and management in cardiovascular sciences
- 8 peer-reviewed journal articles and 1 conference abstract
- 1,126 citations to published research
- 2 papers ranking among the top 0.1% of most-cited Clinical Medicine papers for their respective publication years
The record documented widespread independent reliance on the client’s foundational research into immune responses, vaccine efficacy, and patient engagement in clinical care. Building on this proven track record of analyzing clinical outcomes, the proposed endeavor focused on developing targeted behavioral interventions to improve medication adherence and symptom monitoring for chronic cardiovascular conditions. We emphasized the broader public health significance of these strategies, noting that optimizing patient-managed care for highly prevalent chronic diseases significantly reduced preventable hospitalizations and delivered substantial economic benefits to the healthcare system.
USCIS approved the NIW petition on August 12th, 2026, after just 2 months and 15 days of processing, with premium processing requested. The successful case connected the client’s healthcare background and highly influential research record with a concrete plan for improving how patients manage heart failure outside the clinical setting. We congratulate the client on this approval and wish them continued success in developing scalable approaches that can strengthen cardiovascular care and improve patient outcomes in the United States.

